Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Anne L Schafer

Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON‐PFT Extension I Trials

Journal of Bone and Mineral Research

English

Commercial Laboratory Reproducibility of Serum CTX in Clinical Practice

JBMR Plus

2019

English

Related publications

Bisphosphonate Withdrawal: Effects on Bone Formation and Bone Resorption in Maturing Male Mice

Journal of Bone and Mineral Research

English

Discontinuation of Pediatric Trials

Archivos Argentinos de Pediatria

English

MSX-1 Is Suppressed in Bisphosphonate-Exposed Jaw Bone Analysis of Bone Turnover-Related Cell Signalling After Bisphosphonate Treatment

English

Decreased Bone Mineral Densities (BMD) and Bone Formation Markers During the First Year After Diagnosis of Insulin Dependent Diabetes Mellitus (IDDM) in Children. 431

English

Bone Mineral Density (BMD)

Current Trends in Biomedical Engineering & Biosciences

2017

English

Changes in Bone Sclerostin Levels in Mice After Ovariectomy Vary Independently of Changes in Serum Sclerostin Levels

Journal of Bone and Mineral Research

English

Bone Turnover Changes in Women Treated With Elagolix or Placebo During the Elaris EM-I and EM-II Trials Who Did Not Continue in the Extension Studies

Fertility and Sterility

Gynecology

Reproductive Medicine

Obstetrics

2018

English

Relationship Between the Timing of Relapse and Plasma Drug Levels Following Discontinuation of Cariprazine Treatment in Patients With Schizophrenia: Indirect Comparison With Other Second-Generation Antipsychotics After Treatment Discontinuation

Neuropsychiatric Disease and Treatment

2019

English

Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy

JAMA Internal Medicine

Internal Medicine

2014

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Anne L Schafer

Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON‐PFT Extension I Trials

Commercial Laboratory Reproducibility of Serum CTX in Clinical Practice

Related publications

Bisphosphonate Withdrawal: Effects on Bone Formation and Bone Resorption in Maturing Male Mice

Discontinuation of Pediatric Trials

MSX-1 Is Suppressed in Bisphosphonate-Exposed Jaw Bone Analysis of Bone Turnover-Related Cell Signalling After Bisphosphonate Treatment

Decreased Bone Mineral Densities (BMD) and Bone Formation Markers During the First Year After Diagnosis of Insulin Dependent Diabetes Mellitus (IDDM) in Children. 431

Bone Mineral Density (BMD)

Changes in Bone Sclerostin Levels in Mice After Ovariectomy Vary Independently of Changes in Serum Sclerostin Levels

Bone Turnover Changes in Women Treated With Elagolix or Placebo During the Elaris EM-I and EM-II Trials Who Did Not Continue in the Extension Studies

Relationship Between the Timing of Relapse and Plasma Drug Levels Following Discontinuation of Cariprazine Treatment in Patients With Schizophrenia: Indirect Comparison With Other Second-Generation Antipsychotics After Treatment Discontinuation

Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy